Literature DB >> 9230818

Effect of repair strategy on hospital cost for infants with tetralogy of Fallot.

R M Ungerleider1, R J Kanter, M O'Laughlin, A R Bengur, P A Anderson, J R Herlong, J Li, B E Armstrong, M E Tripp, A Garson, J N Meliones, J Jaggers, S P Sanders, W J Greeley.   

Abstract

OBJECTIVE: This study compares the total hospital cost (HC) for one-stage versus "two-stage" repair of tetralogy of Fallot (TOF) in infants younger than 1 year of age. SUMMARY BACKGROUND DATA: Total (one-stage) correction of TOF is now being performed with excellent results in infancy. Alternatively, a two-stage approach, with palliation of infants in the first year of life, followed by complete repair at a later time can be used. In some institutions, the two-stage approach is standard practice for infants younger than 1 year of age or is used selectively in patients with an anomalous coronary artery across the right ventricular outflow tract (RVOT), "small pulmonary arteries," multiple congenital anomalies, critical illnesses (CI), which increase the risk of bypass (e.g., sepsis or DIC), or severe hypercyanotic spells (HS) at the time of presentation. The cost implications of these two approaches are unknown.
METHODS: The authors reviewed 22 patients younger than 1 year of age who underwent repair of TOF at their institution between 1993 and 1995. Eighteen patients had one-stage (1 degree) repair (mean age, 3.4 +/- 3.1 months; range, 3 days-9 months) and 4 patients were treated by a staged approach with initial palliation (1.6 +/- 0.4 month; range, 1.5-2 months) followed by later repair (14.75 +/- 1.5 months; range, 13-16 months). The reasons for palliation were severe HS at time of presentation (two patients), anomalous coronary artery (one patient) and CI (one patient). In the 18 patients undergoing 1 degree repair, 3 (16.6%) presented with HS, 6 (33.3%) had a transanular repair, and 6 (33.3%) were able to be repaired through an entirely transatrial approach (youngest patient, 1.5 months). The HC (1996 dollars) and hospital length of stay (LOS; days) were evaluated for all patients. The HCs were calculated using transition I, which is a cost accounting system used by our medical center since July 1992. Transition I provides complete data on all direct and indirect hospital-based, nonprofessional costs.
RESULTS: There was no mortality in either group. The group undergoing 1 degree repair had an average LOS of 14.5 +/- 11.2 days compared to an average LOS for palliation of 14 +/- 6.4 days. When the palliated group returned for complete repair, the average LOS was 28.8 +/- 25 days, yielding a total LOS for the two-stage strategy of 43 +/- 30.8 days (p = 0.003 compared to 1 degree repair). The HC for 1 degree repair was $32,541 +/- $15,968 compared to $25,737 +/- $1900 for palliation (p = not significant compared to 1 degree repair) and $54,058 +/- $39,395 for subsequent complete repair (p = not significant compared to 1 degree repair) (total two-stage repair HC = $79,795 +/- $40,625; p = 0.001 compared to 1 degree repair). The LOS and HC for the two-stage group combine a total of palliation plus later repair and, as such, reflect two separate hospitalizations and convalescent periods. To eliminate cost outliers, a best-case analysis was performed by eliminating 50% of patients from each group. Using this analysis, the two-stage approach resulted in an average (total) LOS of 16.5 +/- 2.1 days compared to 8.5 +/- 1.4 days for the 1 degree group. Total cost for the two-stage strategy in this best-case group was $44,660 +/- $3645 compared to $22,360 +/- $3331 for 1 degree repair (p = 0.00001).
CONCLUSIONS: The data from this review show that palliation alone generates HC similar to that from 1 degree infant repair of TOF, and total combined HC and LOS for palliation plus eventual repair of TOF (two-stage approach) are significantly higher than from 1 degree repair. Furthermore, these data do not include additional costs for care delivered between palliation and repair (e.g., outpatient visits, cardiac catheterization, serial echocardiography). Although there may be occasions when a strategy using initial palliation followed by later repair may seem prudent, the cost is clearly higher and use of health care resources greater.

Entities:  

Mesh:

Year:  1997        PMID: 9230818      PMCID: PMC1190888          DOI: 10.1097/00000658-199706000-00015

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  26 in total

1.  Subclavian arterioplasty for the ipsilateral Blalock-Taussig shunt.

Authors:  H Laks; A R Castaneda
Journal:  Ann Thorac Surg       Date:  1975-03       Impact factor: 4.330

2.  Direct vision intracardiac surgical correction of the tetralogy of Fallot, pentalogy of Fallot, and pulmonary atresia defects; report of first ten cases.

Authors:  C W LILLEHEI; M COHEN; H E WARDEN; R C READ; J B AUST; R A DEWALL; R L VARCO
Journal:  Ann Surg       Date:  1955-09       Impact factor: 12.969

3.  Past, present, and future of palliative shunts.

Authors:  P A Ebert
Journal:  Adv Cardiol       Date:  1979

4.  Results of two-stage surgical treatment of tetralogy of Fallot.

Authors:  E Arciniegas; Z Q Farooki; M Hakimi; E W Green
Journal:  J Thorac Cardiovasc Surg       Date:  1980-06       Impact factor: 5.209

5.  Classic shunting operations as part of two-stage repair for tetralogy of Fallot.

Authors:  E Arciniegas; E H Blackstone; A D Pacifico; J W Kirklin
Journal:  Ann Thorac Surg       Date:  1979-06       Impact factor: 4.330

6.  Routine primary repair vs two-stage repair of tetralogy of Fallot.

Authors:  J W Kirklin; E H Blackstone; A D Pacifico; R N Brown; L M Bargeron
Journal:  Circulation       Date:  1979-08       Impact factor: 29.690

7.  The first open-heart repairs of ventricular septal defect, atrioventricular communis, and tetralogy of Fallot using extracorporeal circulation by cross-circulation: a 30-year follow-up.

Authors:  C W Lillehei; R L Varco; M Cohen; H E Warden; C Patton; J H Moller
Journal:  Ann Thorac Surg       Date:  1986-01       Impact factor: 4.330

8.  Modified Blalock-Taussig shunt in newborn infants.

Authors:  M N Ilbawi; J Grieco; S Y DeLeon; F S Idriss; A J Muster; T E Berry; J Klich
Journal:  J Thorac Cardiovasc Surg       Date:  1984-11       Impact factor: 5.209

9.  Systemic-pulmonary shunts in infants and children. Early and late results.

Authors:  J J Lamberti; J Carlisle; J D Waldman; F A Lodge; S E Kirkpatrick; L George; J W Mathewson; S W Turner; S J Pappelbaum
Journal:  J Thorac Cardiovasc Surg       Date:  1984-07       Impact factor: 5.209

10.  Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.

Authors:  M R de Leval; R McKay; M Jones; J Stark; F J Macartney
Journal:  J Thorac Cardiovasc Surg       Date:  1981-01       Impact factor: 5.209

View more
  10 in total

1.  Complete repair of tetralogy of Fallot in the neonate: results in the modern era.

Authors:  J C Hirsch; R S Mosca; E L Bove
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

2.  Alternative repair strategies for ductal-dependent tetralogy of fallot and short-term postoperative outcomes, a multicenter analysis.

Authors:  Matthew B Steiner; Xinyu Tang; Jeffrey M Gossett; Brandon W Beam; Sadia Malik; Parthak Prodhan; Michael J Angtuaco
Journal:  Pediatr Cardiol       Date:  2014-08-28       Impact factor: 1.655

3.  The Limited Benefit of Follow-Up Echocardiograms After Repair of Tetralogy of Fallot.

Authors:  Jack Xu; Caleb Guthrey; Stephen Dalby; Xinyu Tang; Joshua Daily; R Thomas Collins
Journal:  Pediatr Cardiol       Date:  2019-09-18       Impact factor: 1.655

4.  White matter protection in congenital heart surgery.

Authors:  Nobuyuki Ishibashi; Joseph Scafidi; Akira Murata; Ludmila Korotcova; David Zurakowski; Vittorio Gallo; Richard A Jonas
Journal:  Circulation       Date:  2012-01-12       Impact factor: 29.690

5.  Tetralogy of Fallot.

Authors:  Samantha C. Gouw; Thuy-Nga Le; Narayanswami Sreeram
Journal:  Curr Treat Options Cardiovasc Med       Date:  2001-10

6.  Center variation in hospital costs for patients undergoing congenital heart surgery.

Authors:  Sara K Pasquali; Jie-Lena Sun; Phil d'Almada; Robert D B Jaquiss; Andrew J Lodge; Neal Miller; Alex R Kemper; Carole M Lannon; Jennifer S Li
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2011-04-19

Review 7.  Cost comparisons of pharmacological strategies in open-heart surgery.

Authors:  Prabashni Reddy; Jessica Song
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

8.  22q11.2 Deletion syndrome is associated with perioperative outcome in tetralogy of Fallot.

Authors:  Laura Mercer-Rosa; Nelangi Pinto; Wei Yang; Ronn Tanel; Elizabeth Goldmuntz
Journal:  J Thorac Cardiovasc Surg       Date:  2013-01-11       Impact factor: 5.209

9.  Development of a charge adjustment model for cardiac catheterization.

Authors:  Andrew Brennan; Kimberlee Gauvreau; Jean Connor; Cheryl O'Connell; Sthuthi David; Melvin Almodovar; James DiNardo; Puja Banka; John E Mayer; Audrey C Marshall; Lisa Bergersen
Journal:  Pediatr Cardiol       Date:  2014-08-12       Impact factor: 1.655

10.  Lifetime costs and outcomes of repair of Tetralogy of Fallot compared to natural progression of the disease: Great Ormond Street Hospital cohort.

Authors:  Rachael Maree Hunter; Mark Isaac; Alessandra Frigiola; David Blundell; Kate Brown; Kate Bull
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.